Delving Into Participation Patterns in Social Anxiety Studies

Not yet recruiting

• Conditions: Social Anxiety

• Registration Number: NCT06020170
• Lead Sponsor: Power Life Sciences Inc.

Brief Summary

The study seeks to delve into the firsthand experiences of patients diagnosed with social anxiety who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals.

By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future social anxiety patients and play an active role in advancing medical research.

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-08
• Study First Submitted: 2023-08-25
• Study First Submitted QC: 2023-08-25
• Last Update Submitted: 2023-08-25
• Study First Posted: 2023-08-31
• Last Update Posted: 2023-08-31
• Study Start: 2024-09
• Primary Completion: 2025-09
• Study Completion: 2026-09

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Patient has self-identified as planning to enroll in a clinical trial
• Patient has been diagnosed with social anxiety
• Patient is a minimum of 18 years or older

Exclusion Criteria

• Patient does not understand, sign, and return consent form
• Inability to perform regular electronic reporting
• Patient is pregnant

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of patients who decide to participate in a social anxiety clinical trial	3 months
Rate of patients who remain in social anxiety clinical trial to trial completion	12 months

Trial Locations

Locations (1)

Power Life Sciences; 🇺🇸 San Francisco, California, United States